Hamid Khoja
Vermögen: 3 553 $ am 31.05.2026
Vermögen: 3 553 $ am 31.05.2026
Hamid Khoja is currently Chief Scientific Officer at FibroBiologics, Inc. since 2021.
Formerly, worked as Principal Scientist at Covaris LLC from 2009 to 2021, and as Scientist at Chiron Corp.
and Eli Lilly & Co. Education includes a doctorate from Boston University and an undergraduate degree from the University of Southern California.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FIBROBIOLOGICS, INC. 0,06 % | 04.05.2026 | 3.063 ( 0,06 % ) | 3 553 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| FIBROBIOLOGICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Covaris LLC
Covaris LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments, consumables & reagents | Corporate Officer/Principal | 01.08.2021 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Technik-/Wissenschafts-/F&E-Leiter | - |
| ELI LILLY AND COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Covaris LLC
Covaris LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments, consumables & reagents | Health Technology |
FibroBiologics, Inc.
FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen